datafinance

63 results found.

Top Stocks matching your search for "data finance"

Click Learn More to know about Stock Advisor's top picks. We've 3x'd the S&P 500 over the last 20 years.

02/1002/1502/2102/2403/0103/0603/0903/1403/1703/22
HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 23, 2023

$LUNR $LAZR $HKD very few shares on L2 data for $TISI …never miss..

Jan, 12, 2023

$HKD $BIOR $AVCT $TSLA $PRTY The 100% free A.I #tr... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
DAIO

Data io Corp.

7.69%

$4.55 - $4.90

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Dec, 8, 2022

#GoldenCross $DAIO at 3.76 R9 HiLo 44% T1Y 7 stro... See more

Oct, 28, 2022

$DAIO Data I/O shares are trading higher after the... See more

02/0902/1402/1702/2302/2803/0303/0803/1303/1603/21
SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

PROC data are excellent compared to any combo trials.

Mar, 17, 2023

The cash should last them till after GFH-009 P2 da... See more

HKD

AMTD Digital Inc - ADR

-24.37%

$9.48 - $7.17

Feb 8th 2023 - Mar 22nd 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Feb, 23, 2023

$LUNR $LAZR $HKD very few shares on L2 data for $TISI …never miss..

Jan, 12, 2023

$HKD $BIOR $AVCT $TSLA $PRTY The 100% free A.I #trading room is a great place to see this #fintech #Software scanning live and get questions on our data answered.

DAIO

Data io Corp.

7.69%

$4.55 - $4.90

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

No reviews available.

SLS

SELLAS Life Sciences Group Inc

-63.99%

$3.61 - $1.30

Feb 7th 2023 - Mar 21st 2023

Positive Reviews Happy Facepositive
Negative Reviews Sad Facenegative

Mar, 20, 2023

PROC data are excellent compared to any combo trials.

Mar, 17, 2023

The cash should last them till after GFH-009 P2 data and REGAL P3 data.

Mar, 17, 2023

Very Exciting - management has seen the GFH OS / and Cr data that is measured in weeks.

Mar, 8, 2023

Hugely valuable when GFH Final Data comes in w a 30% plus CR rate for r/r AML 3 previous lines $MRK $bmy deals in play - Next Week

Mar, 8, 2023

But yesterdays paper also has me considering, if there isn't a deal with $mrk or $BMY or some other CPI BP --- That data is Best In Class - best in clinic, best in trial too.

Feb, 24, 2023

This will go beyond parabolic on good data … literally no shares out there unless they offer new ones … $MDGL $VKTX $SLS $SAVA

Feb, 24, 2023

Early data were amazing could easily do MDGL

Feb, 6, 2023

$MRK Ovarian cancer data final P2 results are better than any other drugs by a mile.

Jan, 17, 2023

but positive news on the data side & you can see the mass accumulation cycle highlighted in green.

Jan, 17, 2023

Gps + Opdivo $bmy Meso data due now will be better than all other treatments.